Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-26 @ 3:18 PM
NCT ID:
NCT07439458
Eligibility Criteria:
Inclusion Criteria (intervention group):
* Reproductive age (premenopausal);
* Diagnosis of Stage II-III Triple-Negative Breast Cancer (TNBC) (negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2));
* Timeframe of 3 to 9 months after completion of surgery, adjuvant chemotherapy, radiation therapy, and/or immunotherapy;
* Physician-certified (cardiologist) physical fitness for exercise testing, supported by echocardiography (ECHO).
Inclusion Criteria (control group):
* Reproductive age (premenopausal);
* No current or prior diagnosis of any type of cancer;
* Matched by age, body constitution, and physical fitness to the breast cancer participant group.
Exclusion Criteria:
* Pregnancy;
* Autoimmune diseases (e.g., thyroiditis, inflammatory bowel disease, atopic dermatitis, etc.);
* Endocrine disorders (e.g., metabolic syndrome, diabetes);
* Cardiovascular diseases;
* Diagnosis of any other type of oncological disease;
* Any condition for which physical activity is contraindicated (e.g., asthma, COPD, spinal disc herniation, severe iron deficiency anemia).
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
35 Years
Study:
NCT07439458
Study Brief:
Protocol Section:
NCT07439458